Biotech leaders urge Senate to restore FDA's key functions, cite funding concerns for small companies - Fierce Biotech
More than 200 biotech leaders have penned a letter voicing concerns over the FDA’s capacity after mass federal layoffs, specifically for small biotechs that depend on investor backing to meet agenc | More than 200 biotech leaders have penned a letter voicing …